Inovio Pharmaceuticals
INO
#9666
Rank
NZ$0.20 B
Marketcap
NZ$1.94
Share price
-5.63%
Change (1 day)
-56.07%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -NZ$0.15 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.17 Billion, an increase over its 2024 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.15 Billion-10.84%
2025 -NZ$0.17 Billion-16.07%
2024 -NZ$0.2 Billion-20.03%
2023 -NZ$0.24 Billion-51.56%
2022 -NZ$0.5 Billion-8.26%
2021 -NZ$0.54 Billion95.4%
2020 -NZ$0.28 Billion36.62%
2019 -NZ$0.21 Billion20.19%
2018 -NZ$0.17 Billion10.94%
2017 -NZ$0.16 Billion9.59%
2016 -NZ$0.14 Billion118.9%
2015 -NZ$62.95 Million-10.67%
2014 -NZ$70.47 Million83.32%
2013 -NZ$38.44 Million
2011 -NZ$39.66 Million15.64%
2010 -NZ$34.29 Million37.7%
2009 -NZ$24.91 Million2.19%
2008 -NZ$24.37 Million-14.09%
2007 -NZ$28.37 Million19.12%
2006 -NZ$23.81 Million9.62%
2005 -NZ$21.73 Million5.77%
2004 -NZ$20.54 Million73.08%
2003 -NZ$11.87 Million12.75%
2002 -NZ$10.53 Million
2000 -NZ$15.93 Million53.93%
1999 -NZ$10.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.75 B-31,942.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.69 B-18,958.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.32 B-8,491.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$3.49 Billion 2,275.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.71 B-9,443.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.07 B-9,685.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-NZ$4.92 Million-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.29 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA